Breast cancer risk in primary care: Implications for chemopreventionLEWIS, Carmen L; KINSINGER, Linda S; HARRIS, Russell P et al.Archives of internal medicine (1960). 2004, Vol 164, Num 17, pp 1897-1903, issn 0003-9926, 7 p.Article

Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention : American Society of Clinical Oncology/ American Urological Association 2008 Clinical Practice GuidelineKRAMER, Barnett S; HAGERTY, Karen L; HARRIS, Russell P et al.Journal of clinical oncology. 2009, Vol 27, Num 9, pp 1502-1516, issn 0732-183X, 15 p.Article

Behavioral Counseling After Screening for Alcohol Misuse in Primary Care: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task ForceJONAS, Daniel E; GARBUTT, James C; YEATTS, John et al.Annals of internal medicine. 2012, Vol 157, Num 9, pp 645-654, issn 0003-4819, 10 p.Article

Use of 5a-Reductase Inhibitors for Prostate Cancer Chemoprevention : American Society of Clinical Oncology/ American Urological Association 2008 Clinical Practice GuidelineKRAMER, Barnett S; HAGERTY, Karen L; HARRIS, Russell P et al.The Journal of urology. 2009, Vol 181, Num 4, pp 1642-1657, issn 0022-5347, 16 p.Article

The Harms of Screening: A Proposed Taxonomy and Application to Lung Cancer ScreeningHARRIS, Russell P; SHERIDAN, Stacey L; LEWIS, Carmen L et al.JAMA internal medicine (Print). 2014, Vol 174, Num 2, pp 281-285, issn 2168-6106, 5 p.Article

Retrospective classification of prostate-specific antigen tests: Differentiating screening from diagnostic clinical encountersGODLEY, Paul A; RATHORE, Saif S; KSHIRSAGAR, Ashutosh V et al.Journal of clinical epidemiology. 2001, Vol 54, Num 9, pp 884-888, issn 0895-4356Article